P. V. van Santbrink

发表

Leukocyte-Specific CCL3 Deficiency Inhibits Atherosclerotic Lesion Development by Affecting Neutrophil Accumulation

T. V. van Berkel, J. Kuiper, I. Bot, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor.

G. A. van der Marel, A. Valentijn, T. V. van Berkel, 1999, Journal of medicinal chemistry.

A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy

A. IJzerman, H. de Vries, L. Heitman, 2017, Scientific Reports.

Stimulation of Liver-Directed Cholesterol Flux in Mice by Novel N-Acetylgalactosamine–Terminated Glycolipids With High Affinity for the Asialoglycoprotein Receptor

H. Schifferstein, T. V. van Berkel, P. Rensen, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Y-Box Binding Protein-1 Controls CC Chemokine Ligand-5 (CCL5) Expression in Smooth Muscle Cells and Contributes to Neointima Formation in Atherosclerosis-Prone Mice

Regina M. Krohn, A. Zernecke, C. Weber, 2007, Circulation.

Lipocalin-2 contributes to experimental atherosclerosis in a stage-dependent manner.

P. Quax, J. Kuiper, I. Bot, 2018, Atherosclerosis.

Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation.

G. Pasterkamp, J. Kuiper, I. Bot, 2014, Atherosclerosis.

Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE-/- mice.

T. V. van Berkel, I. Bot, H. Hilpert, 2011, Cardiovascular research.

Oxidized Low-Density Lipoprotein–Induced Apoptotic Dendritic Cells as a Novel Therapy for Atherosclerosis

J. Kuiper, I. Bot, S. D. de Jager, 2015, The Journal of Immunology.

Mesenchymal Stem Cells Reduce Murine Atherosclerosis Development

J. Kuiper, I. Bot, S. D. de Jager, 2015, Scientific Reports.

NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice—Brief Report

J. Kuiper, I. Bot, J. van Duijn, 2017, Arteriosclerosis, thrombosis, and vascular biology.

Impaired Effector Memory T-Cell Regulation Facilitates Graft Versus Host Disease in CCR7-Deficient Bone Marrow Transplant Chimeras

T. V. van Berkel, J. Kuiper, P. Aukrust, 2009, Transplantation.

Complement factor C5a as mast cell activator mediates vascular remodelling in vein graft disease.

J. Hamming, P. Quax, T. Woodruff, 2013, Cardiovascular research.

T-Cell Immunoglobulin and Mucin Domain 3 Acts as a Negative Regulator of Atherosclerosis

J. Kuiper, I. Bot, H. Yagita, 2013, Arteriosclerosis, thrombosis, and vascular biology.

Interference of the CD30–CD30L Pathway Reduces Atherosclerosis Development

J. Kuiper, I. Bot, H. Yagita, 2012, Arteriosclerosis, thrombosis, and vascular biology.

Hematopoietic Sphingosine 1-Phosphate Lyase Deficiency Decreases Atherosclerotic Lesion Development in LDL-Receptor Deficient Mice

J. Nofer, C. Müller-Tidow, T. V. van Berkel, 2013, PloS one.

Blockade of the BLT1-LTB4 axis does not affect mast cell migration towards advanced atherosclerotic lesions in LDLr−/− mice

J. Kuiper, I. Bot, B. Slütter, 2022, Scientific Reports.

Leukocyte Cathepsin S Is a Potent Regulator of Both Cell and Matrix Turnover in Advanced Atherosclerosis

J. Jukema, E. E. van der Wall, P. Kovanen, 2009, Arteriosclerosis, thrombosis, and vascular biology.

CD11b+Gr-1+ myeloid-derived suppressor cells reduce atherosclerotic lesion development in LDLr deficient mice.

L. Boon, Jolien Wolbert, J. Kuiper, 2016, Cardiovascular research.

Agonistic Anti-TIGIT Treatment Inhibits T Cell Responses in LDLr Deficient Mice without Affecting Atherosclerotic Lesion Development

J. Kuiper, I. Bot, A. Foks, 2013, PloS one.

A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy

Wilhelmus E. A. de Witte, A. IJzerman, H. de Vries, 2017, Scientific Reports.

persistent knockdown of CCR2 function in vivo Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to

J. Seppen, T. V. van Berkel, T. V. Berkel, 2013 .

Diet-induced dyslipidemia induces metabolic and migratory adaptations in regulatory T cells

T. Hankemeier, H. Chi, A. Harms, 2020, Cardiovascular research.

Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness

P. Doevendans, T. van der Poll, G. Pasterkamp, 2014, Scientific Reports.

Adenosine A2B Receptor Agonism Inhibits Neointimal Lesion Development After Arterial Injury in Apolipoprotein E–Deficient Mice

A. IJzerman, H. de Vries, J. V. van Veldhoven, 2012, Arteriosclerosis, thrombosis, and vascular biology.

Quaking, an RNA-Binding Protein, Is a Critical Regulator of Vascular Smooth Muscle Cell Phenotype

M. Goumans, S. Richard, J. Jukema, 2013, Circulation research.

Hematopoietic S1P Lyase Deficiency Inhibits Atherogenesis

J. Nofer, C. Müller-Tidow, T. V. van Berkel, 2009 .

Inhibition of lysophosphatidic acid receptors 1 and 3 attenuates atherosclerosis development in LDL-receptor deficient mice

J. Kuiper, I. Bot, M. Swart, 2016, Scientific Reports.

Defective Autophagy in T Cells Impairs the Development of Diet-Induced Hepatic Steatosis and Atherosclerosis

J. Kuiper, I. Bot, F. Schaftenaar, 2018, Front. Immunol..

Znf202 Affects High Density Lipoprotein Cholesterol Levels and Promotes Hepatosteatosis in Hyperlipidemic Mice

T. Mahmoudi, K. V. van Dijk, T. V. van Berkel, 2013, PloS one.

Proteoglycan 4 regulates macrophage function without altering atherosclerotic lesion formation in a murine bone marrow-specific deletion model.

G. Dallinga-Thie, J. Kuivenhoven, M. Hoekstra, 2018, Atherosclerosis.

Macrophage ABCA2 deletion modulates intracellular cholesterol deposition, affects macrophage apoptosis, and decreases early atherosclerosis in LDL receptor knockout mice.

K. Tew, M. de Graauw, T. V. van Berkel, 2012, Atherosclerosis.

An Unexpected Intriguing Effect of Toll-Like Receptor Regulator RP105 (CD180) on Atherosclerosis Formation With Alterations on B-Cell Activation

J. Jukema, P. Quax, J. Kuiper, 2013, Arteriosclerosis, thrombosis, and vascular biology.

CXCR4 blockade induces atherosclerosis by affecting neutrophil function.

V. Hérias, A. Zernecke, R. Koenen, 2014, Journal of molecular and cellular cardiology.

Leukocyte TLR5 deficiency inhibits atherosclerosis by reduced macrophage recruitment and defective T-cell responsiveness

I. Hoefer, S. D. de Jager, G. Ellenbroek, 2017, Scientific Reports.